U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06921941) titled 'Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin' on March 27.
Brief Summary: Drug-drug interaction study between Bemnifosbuvir/Ruzasvir and Digoxin or Rosuvastatin
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer Study
Intervention:
DRUG: Digoxin vs Digoxin + BEM/RZR vs Digoxin + 2h BEM/RZR
Treatment-A (Digoxin): A single dose of digoxin will be administered under fasting conditions.
Treatment-B (Digoxin + BEM/RZR): A single dose of digoxin will be co-administered a single dose of BEM/RZR under fasting conditions.
Treatment-C (Digoxin + 2h BE...